© 2020 MJH Life Sciences and OncLive. All rights reserved.
July 16, 2020
Nancy U. Lin, MD, discusses the treatment landscape in HER2-positive metastatic breast cancer.
February 12, 2020
Nancy Lin, MD, discusses central nervous system–specific outcomes with neratinib (Nerlyx) in HER2-positive breast cancer.
December 13, 2019
Nancy Lin, MD, discusses the impact of neratinib on development and progression of central nervous system metastases in patients with HER2-positive metastatic breast cancer.